PME.ASX: PME signs 5-year, A$10M deal with University Heidelberg

PME signs 5-year, A$10M deal with University Heidelberg

Stock	Pro Medicus Ltd (PME.ASX)
Release Time	8 Oct 2025, 9:19 a.m.
Price Sensitive	Yes

This feature provides summaries of price-sensitive announcements for companies followed by users on InvestorPA. The summaries are generated by large language models so please interpret with care.

Pro Medicus signs A$10M deal with University Heidelberg

Key Points

5-year Enterprise PACS contract with University Hospital Heidelberg (UKHD) and German Cancer Research Institute (DKFZ)
Expands Visage footprint in key German/European market
Consolidates three legacy PACS systems

Full Summary

Pro Medicus Limited, a leading healthcare informatics company, has announced that its wholly-owned European subsidiary, Visage Imaging, GmbH, has signed a 5-year, A$10M Enterprise PACS deal with University Hospital Heidelberg (UKHD) and German Cancer Research Institute (DKFZ), as well as associated hospitals Thoraxklink Heidelberg and KKH Bergstrasse. UKHD is one of Germany's largest and most renowned academic medical centers, with approximately 2,600 beds and nearly 14,000 staff members. DKFZ is Germany's largest biomedical research institution, with over 3,400 employees from more than 90 nations, comprising approximately 1,490 scientists. UKHD and DKFZ form the core of one of Europe's preeminent hubs for cancer research and treatment. The Visage 7 Enterprise Imaging Platform will enable UKHD and DKFZ to consolidate their disparate legacy systems, streamline workflows, and provide clinicians with advanced diagnostic tools. The platform will also empower researchers to integrate imaging into clinical trials and translational studies at unprecedented speed and scale, while providing the foundation to bring new discoveries into clinical practice.